Core Points - The company has announced changes to its registered address, the cancellation of its supervisory board, and amendments to its articles of association [4][5][6] - The board of directors has confirmed the accuracy and completeness of the announcement, ensuring no misleading statements or omissions [4][6] - The company will no longer have a supervisory board, with the audit committee taking over its responsibilities in accordance with the revised Company Law and relevant regulations [5][6] Group 1: Company Changes - The registered address will be changed from "Building A, 22nd Floor, No. 10 Ronghua Middle Road, Beijing Economic and Technological Development Zone" to "Unit 2202-2, 19th Floor, No. 10 Ronghua Middle Road, Beijing Economic and Technological Development Zone" [4] - The supervisory board will be abolished, and its functions will be assumed by the audit committee, in line with the latest legal requirements [5][6] - The articles of association will be systematically revised to improve the governance structure, including the removal of references to the supervisory board and its members [6][7] Group 2: Governance and Compliance - The company will ensure compliance with the revised Company Law and the Shanghai Stock Exchange's listing rules [5][6] - The board has expressed gratitude to the outgoing supervisory board members for their contributions during their tenure [6] - The management is authorized to handle the necessary business registration changes and document signing related to these amendments [7]

北京佰仁医疗科技股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日召开第三届董事会第十一次会议，审议通过了《关于取消公司监事会的议案》 《关于变更公司注册资本、修订 <公司章程> 并办理工商变更登记的议案》，同 日召开第三届监事会第八次会议，审议通过了《关于取消公司监事会的议案》。 现将有关情况说明如下： 证券代码：688198 证券简称：佰仁医疗 公告编号：2025-028 北京佰仁医疗科技股份有限公司 关于变更公司注册资本、取消监事会、修订《公司 章程》并办理工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、变更公司注册资本的情况 公司于 2025 年 6 月 13 日召开第三届董事会第十次会议、第三届监事会第 七次会议，审议通过了《关于公司 2020 年限制性股票激励计划首次授予部分第 五个归属期符合归属条件的议案》《关于公司 2020 年限制性股票激励计划预留 授予部分第三个归属期符合归属条件的议案》。2025 年 7 月 23 日，公司 2020 年 限制性股票激励计划首次授 ...

Core Viewpoint - Shouyao Holdings (Beijing) Co., Ltd. is undergoing significant corporate governance changes, including a change of registered address, the cancellation of the supervisory board, and amendments to the Articles of Association to align with updated regulations and improve governance structure [1][2][3]. Group 1: Change of Registered Address - The registered address of Shouyao Holdings is changing from "No. 10 Ronghua Middle Road, Beijing Economic and Technological Development Zone, Building 1, A Seat, 22nd Floor, Room 2205" to "No. 10 Ronghua Middle Road, Beijing Economic and Technological Development Zone, Building 1, 19th Floor, Unit 2202-2" [1]. Group 2: Cancellation of Supervisory Board - The company will no longer have a supervisory board, with the audit committee of the board of directors assuming the supervisory functions as per the latest revisions of the Company Law and related regulations [1][2]. - The current supervisory board members will continue their roles until the first extraordinary general meeting of shareholders in 2025, where the cancellation will be formally approved [2]. Group 3: Amendments to Articles of Association - The Articles of Association will be systematically revised to enhance the governance structure, including the removal of references to the supervisory board and the introduction of terms related to the audit committee [1][2]. - Key changes include the unification of terms from "shareholders' meeting" to "shareholders' assembly" and the removal of all references to "supervisors" and "supervisory board" [2]. - The revised Articles of Association will be disclosed on the Shanghai Stock Exchange website [2]. Group 4: Authorization for Changes - The board of directors will seek authorization from the shareholders' meeting to allow management to handle the necessary business registration changes and amendments to the Articles of Association [3].

Core Viewpoint - The company plans to distribute cash dividends to shareholders based on its financial performance for the first half of 2025, while also proposing structural changes to its governance by abolishing the supervisory board and amending its articles of association [1][2]. Financial Performance and Dividend Distribution - As of June 30, 2025, the company's undistributed profits amounted to 16,864,833.16 yuan, with a proposed cash dividend of 0.15 yuan per 10 shares, totaling approximately 7,800,998.84 yuan [1]. - The total share capital as of the same date was 520,066,589 shares, and the proposed cash dividend represents 7.49% of the company's net profit [1]. Governance Changes - The company intends to abolish the supervisory board to enhance its governance structure, transferring the supervisory responsibilities to the audit committee of the board of directors [2]. - Amendments to the articles of association will include expanding the business scope to include retail of pharmaceuticals and internet services related to medical devices [2][3]. Articles of Association Amendments - The revisions to the articles of association will reflect changes in governance and operational scope, ensuring compliance with relevant laws and regulations [3][4]. - Specific amendments include the addition of new business activities and the restructuring of the roles and responsibilities of the board and management [4][5].

Summary of Key Points Core Viewpoint The announcement details the changes in the corporate governance structure of Anhui Xindong Link Micro System Co., Ltd., including the cancellation of the supervisory board, amendments to the articles of association, and updates to the company's registration capital. Group 1: Changes in Capital and Governance Structure - The company has completed the registration of additional shares from the 2023 restricted stock incentive plan, increasing the total number of shares from 400,606,400 to 400,715,660, and the registered capital from RMB 400,606,400 to RMB 400,715,660 [1][2][6] - The supervisory board has been canceled to enhance governance efficiency, with the audit committee of the board taking over its responsibilities [2][3] - The amendments to the articles of association were made in accordance with relevant laws and regulations, ensuring the protection of the rights of shareholders and creditors [2][3][4] Group 2: Specific Amendments to Articles of Association - The articles of association were revised to reflect the new governance structure and to ensure compliance with the Company Law and Securities Law [3][4][5] - The company’s registered name and address remain unchanged, with the registered capital now officially updated [4][5] - The articles now specify that the company’s total shares are 400,715,660, all of which are ordinary shares [6][7]

Core Viewpoint - The announcement by Hu Silicon Industry on August 18 indicates significant changes in the company's board and management structure, including the election of new directors and the appointment of key executives [1] Group 1: Board and Management Changes - Hu Silicon Industry will hold its third extraordinary shareholders' meeting and the first meeting of the third board of directors on August 15, 2025, to complete the board re-election and the appointment of senior management and securities representatives [1] - Six individuals, including Jiang Haitao, were elected as non-independent directors, while three, including Xia Hongliu, were elected as independent directors [1] - Jiang Haitao was elected as the chairman, and Feng Qian was appointed as the vice chairman [1] Group 2: Executive Appointments - Qiu Ciyun was appointed as the president, and Li Wei was appointed as the executive vice president [1] - Wang Yan was designated as the securities affairs representative [1] Group 3: Structural Changes - Following the re-election, some directors and executives, including Yu Yuehui, will leave their positions, and the company will no longer have a supervisory board, with the audit committee assuming related responsibilities [1]

证券代码：600409 证券简称：三友化工 公告编号：临 2025-034 号 唐山三友化工股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 唐山三友化工股份有限公司（以下简称"公司"）于 2025 年 8 月 12 日召开 述的议案》《关于取消监事会的议案》《关于修订 <公司章程> 的议案》《关于 修订 <公司股东会议事规则> 的议案》《关于修订〈公司董事会议事规则〉的议 案》，公司董事会同意公司增加公司经营范围、取消监事会、修订《公司章程》 及配套附件，并授权公司管理层办理公司章程变更登记备案相关事宜。上述议案 尚需提交公司股东大会审议通过。现将有关事项公告如下： 一、增加公司经营范围并规范表述情况 根据业务发展需要，公司拟在经营范围中增加"劳务服务（不含劳务派遣）； 普通机械设备安装服务"，同时根据唐山市行政审批局要求规范整体经营范围表 述。具体调整如下： 调整前 调整后 纯碱、食用添加剂碳酸钠、轻质碳酸 一般事项：化工产品销售（不含许可类化工产品）；化工 钙、工业液体氯化钙、工业二水氯化 产品生产（不含许可 ...

证券代码：603037 证券简称：凯众股份 公告编号：2025-038 上海凯众材料科技股份有限公司 关于变更公司注册资本、取消监事会、修订《公司章程》 及其附件并修订部分制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海凯众材料科技股份有限公司（以下简称"公司"）于 2025 年 8 月 12 日 （星期二）召开第四届董事会第二十五次会议审议通过了《关于变更公司注册资 本及修订 <公司章程> 的议案》《关于取消监事会并修订 <公司章程> 及其附件的议 案》《关于修订公司部分治理制度的议案》，现将相关事项公告如下： 公司于 2025 年 5 月 29 日召开 2024 年年度股东大会审议通过了 《关于 2024 年度利润分配及资本公积转增股本方案的议案》，实施情况如下： 公司以 2025 年 6 月 20 日为股权登记日，向全体股东每股派发现金红利 0.35 元(含税)，以资本公积金每股转增 0.4 股。转增完成后，公司的总股本由 根据上述情况，公司拟相应变更注册资本并修订《公司章程》， 《公司章程》 一、变更注 ...

Core Viewpoint - Tianjin Pharmaceutical Co., Ltd. is proposing to change its business scope, abolish the supervisory board, and amend its articles of association to enhance corporate governance and operational efficiency [1][3][4]. Business Scope Changes - The company plans to expand its business scope to include drug import and export, technology import and export, import and export agency, and goods import and export [1][8]. - The revised business scope will include the following licensed projects: drug production, entrusted drug production, veterinary drug production, cosmetics production, food additive production, feed additive production, hazardous chemicals operation, special equipment design, and drug import and export [1][8]. Articles of Association Amendments - The amendments to the articles of association aim to align with the Company Law and other relevant regulations, ensuring the protection of the rights of the company, shareholders, and creditors [3][4]. - Key changes include the removal of the supervisory board, with the audit and risk control committee of the board of directors assuming the supervisory functions [1][3]. - The articles will also clarify the responsibilities and rights of shareholders, including the ability to sue the company or its directors for breaches of duty [7][14]. Corporate Governance Enhancements - The company emphasizes the importance of maintaining a high standard of corporate governance to protect the interests of shareholders and ensure compliance with legal requirements [1][3]. - The amendments will also address the roles and responsibilities of the general manager and other senior management, ensuring accountability and legal compliance [5][6][7].

Core Viewpoint - Sichuan Furong Technology Co., Ltd. has announced changes to its registered capital, the cancellation of its supervisory board, and amendments to its articles of association and governance systems, which have been approved by the board of directors and the supervisory board [1][2]. Capital Change - The registered capital of the company has been changed to 768,075,621 yuan as of November 15, 2024, and subsequently increased to 997,492,462 yuan after a capital reserve conversion and the conversion of convertible bonds [2][3]. - The total share capital increased from 768,075,621 shares to 997,492,462 shares by June 30, 2025, following the implementation of a capital reserve conversion plan [2][3]. Cancellation of Supervisory Board - The company will no longer have a supervisory board, with its functions being transferred to the audit committee of the board of directors, in accordance with the latest legal and regulatory requirements [2][3]. Amendments to Articles of Association - The company has undertaken a systematic revision of its articles of association to align with current laws and regulations, ensuring the protection of the rights of shareholders, employees, and creditors [3][4]. - The revised articles of association will be submitted for approval at the shareholders' meeting, and the management is authorized to handle all related registration and filing procedures [4][5]. Governance System Revisions - The company has agreed to revise certain governance systems to enhance operational compliance and internal governance mechanisms, reflecting the latest legal and regulatory standards [5][6].